Keros Therapeutics, Inc. (KROS)
17.91
-0.08
(-0.44%)
USD |
NASDAQ |
Jan 30, 16:00
17.88
-0.03
(-0.17%)
After-Hours: 20:00
Keros Therapeutics Shareholders Equity (Quarterly) : 703.58M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| MannKind Corp. | -44.55M |
| Sarepta Therapeutics, Inc. | 1.320B |
| Insmed, Inc. | 945.57M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 742.78M |
| Total Liabilities (Quarterly) | 39.20M |
| Debt to Equity Ratio | 0.0248 |
| Current Ratio | 29.86 |
| Net Debt Paydown Yield | -0.11% |